Cargando…
Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches
Botulinum neurotoxin (BoNT) is produced by the anaerobic, Gram-positive bacterium Clostridium botulinum. As one of the most poisonous toxins known and a potential bioterrosism agent, BoNT is characterized by a complex mode of action comprising: internalization, translocation and proteolytic cleavage...
Autores principales: | Rasetti-Escargueil, Christine, Popoff, Michel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783819/ https://www.ncbi.nlm.nih.gov/pubmed/31547338 http://dx.doi.org/10.3390/toxins11090528 |
Ejemplares similares
-
Variability of Botulinum Toxins: Challenges and Opportunities for the Future
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2018) -
Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2020) -
Recent Developments in Botulinum Neurotoxins Detection
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2022) -
In Silico Conformational Features of Botulinum Toxins A1 and E1 According to Intraluminal Acidification
por: Cottone, Grazia, et al.
Publicado: (2022) -
Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2015)